GlassScriptPhysician profile
Vindya Achuthan
NPI 1114104619
$1,927.81
in general payments reported to CMS, 2019-2025
32 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $58.84 · 2021: $184 · 2022: $203 · 2023: $252 · 2024: $626 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,245.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $432.92 | 2019-2025 | Evenity, Repatha, Krystexxa |
| Abiomed | $218.47 | 2024-2025 | Impella |
| Abbott Laboratories | $177.26 | 2019 | |
| Ucb, INC. | $109.76 | 2022-2025 | Cimzia, Bimzelx |
| Glaxosmithkline, LLC. | $83.43 | 2023-2025 | Trelegy Ellipta |
| Jazz Pharmaceuticals INC. | $73.98 | 2020-2024 | |
| Cook Medical LLC | $73.02 | 2024 | Zenith Spiral-Z |
| Novo Nordisk INC | $65.11 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.75 | 2020-2025 | Jardiance, Cyltezo |
| Mylan Specialty L.P. | $61.32 | 2019-2023 | Yupelri |
| Harmony Biosciences LLC | $60.00 | 2021 | |
| Mannkind Corporation | $44.62 | 2021-2024 | |
| Inspire Medical Systems, INC. | $38.01 | 2024 | Inspire |
| Ultragenyx Pharmaceutical INC. | $35.79 | 2020-2022 | |
| Lilly USA, LLC | $35.38 | 2023 | Mounjaro |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $31.06 | 2022-2025 | Sunosi |
| Tolmar, INC. | $31.04 | 2023 | |
| Xeris Pharmaceuticals, INC. | $30.68 | 2022-2025 | Recorlev |
| Daiichi Sankyo INC. | $29.99 | 2022 | |
| Medtronic, INC. | $29.26 | 2022 | |
| Exact Sciences Corporation | $23.25 | 2023 | Cologuard Collection Kit |
| Corcept Therapeutics | $21.44 | 2024 | Korlym |
| United Therapeutics Corporation | $18.99 | 2025 | Tyvaso |
| Resmed Corp | $18.57 | 2025 | |
| Viatris Specialty LLC | $18.00 | 2025 | Yupelri |
| Hikma Pharmaceuticals USA | $16.53 | 2023 | Ryaltris, Mitigare |
| Alexion Pharmaceuticals, INC. | $15.71 | 2024 | Strensiq |
| Amneal Pharmaceuticals LLC | $14.71 | 2019 | |
| Horizon Therapeutics Plc | $14.70 | 2023 | Krystexxa |
| Mallinckrodt Hospital Products INC. | $14.49 | 2025 | Acthar |
| Pfizer INC. | $14.00 | 2022 | |
| Amarin Pharma, INC. | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vindya Achuthan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.